Proton Pump Inhibitors Linked to Non-Specific Gastric Inflammation in Children

Published Online: Monday, June 9, 2014
Follow Pharmacy_Times:
An increased risk of non-specific gastric inflammation is found in children exposed to PPIs for more than 6 weeks.

Exposure to proton pump inhibitors (PPIs) is associated with non-specific gastric inflammation (NSGI) in children, according to a study published in Pediatric Gastroenterology and Hepatology on January 20, 2014. The risk increases if the patient is exposed to a PPI for a period greater than 6 weeks, and significantly increased after 3 months.

For their study, Eduardo Rosas-Blum and colleagues at the University of Texas reviewed 310 endoscopy and biopsy reports of patients who underwent an esophagogastroduodenoscopy between July 2009 and July 2010.

To read the rest of this article, click here.
Related Articles
The FDA today approved a vaccine for active immunization against diphtheria, tetanus, pertussis, and poliomyelitis for children aged 4 to 6 years.
Many children with food allergies develop micronutrient deficiencies.
Shire’s ADHD treatment, lisdexamfetamine dimesylate (Vyvanse), is now available in a 10-mg titration dose.
While evidence suggests that children with ADHD fare better when treated with both stimulant medication and behavior therapy, a study has found that many of the children who are prescribed ADHD medication do not receive psychotherapy.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$